Natera, Inc.
Matthew Rabinowitz (EXECUTIVE CHAIRMAN) sells NTRA shares
AI-generated summary
EXECUTIVE CHAIRMAN, Director Matthew Rabinowitz exercised 50,000 derivative shares at an average price of $10.41 for a value of $520,500. They also sold 49,400 shares of Common Stock at an average price of $402.70 for a value of $19,893,173.97, and 600 shares of Common Stock at an average price of $398.09 for a value of $238,853.88. Following these transactions, they directly held 2,119,394 shares. The sales were executed under a Rule 10b5-1 trading plan adopted on June 12, 2026.
Key facts
- Insider
- Matthew Rabinowitz · EXECUTIVE CHAIRMAN, Director
Rule 10b5-1 plan · adopted Jun 12, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | M · exercise or conversion of a derivative | +50,000 | $10.41 | $520,500.00 | 2,169,394 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F2 | −286 | $388.32 | $111,059.15 | 2,169,108 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F3 | −714 | $389.84 | $278,345.19 | 2,168,394 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F4 | −600 | $390.21 | $234,123.12 | 2,167,794 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F5 | −300 | $391.58 | $117,473.01 | 2,167,494 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F6 | −800 | $393.47 | $314,777.04 | 2,166,694 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F7 | −300 | $394.39 | $118,318.50 | 2,166,394 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F8 | −1,900 | $396.30 | $752,979.12 | 2,164,494 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F9 | −1,100 | $397.16 | $436,875.12 | 2,163,394 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F10 | −600 | $398.09 | $238,853.88 | 2,162,794 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F11 | −793 | $399.31 | $316,655.05 | 2,162,001 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F12 | −2,671 | $400.31 | $1,069,225.61 | 2,159,330 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F13 | −5,974 | $401.42 | $2,398,094.43 | 2,153,356 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F14 | −6,309 | $402.23 | $2,537,683.58 | 2,147,047 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F15 | −3,858 | $403.27 | $1,555,798.30 | 2,143,189 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F16 | −10,321 | $404.64 | $4,176,305.95 | 2,132,868 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F17 | −6,274 | $405.18 | $2,542,096.18 | 2,126,594 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F18 | −1,400 | $406.63 | $569,281.86 | 2,125,194 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F19 | −3,800 | $407.27 | $1,547,611.56 | 2,121,394 | Direct |
| Oct 15, 2026 | S · open-market saleFootnotes F1, F20 | −2,000 | $408.24 | $816,471.20 | 2,119,394 | Direct |
| Oct 15, 2026 | M · exercise or conversion of a derivativeStock Option (right to buy)Footnotes F21 | −50,000 | $0.00 | $0.00 | 0 | Direct |
Footnotes
- F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026.
- F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $387.97 to $388.70 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $389.06 to $390.05 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $390.08 to $390.33 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $391.55 to $391.60 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $393.15 to $394.08 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $394.52 to $395.23 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $395.69 to $396.68 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $396.75 to $397.62 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F10 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $397.78 to $398.56 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $398.80 to $399.79 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F12 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $399.82 to $400.80 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F13 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $400.82 to $401.79 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F14 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $401.82 to $402.81 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F15 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $402.82 to $403.80 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F16 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $403.83 to $404.82 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F17 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $404.86 to $405.79 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F18 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $405.92 to $406.91 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F19 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $406.92 to $407.87 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F20 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $407.96 to $408.60 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F21 The option shares are fully exercisable.
More NTRA filings
- SC 13G/A
Filed Nov 6, 2026
- 10-Q
Filed Nov 5, 2026
- 8-K
Filed Nov 5, 2026
- SC 13G
Filed Nov 5, 2026
- 4
Filed Nov 4, 2026
- 4
Filed Nov 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.